By Professor Bruce Neal

Journal articles

Perkovic V; Jardine MJ; Neal B; Bompoint S; Heerspink HJL; Charytan DM; Edwards R; Agarwal R; Bakris G; Bull S; Cannon CP; Capuano G; Chu PL; De Zeeuw D; Greene T; Levin A; Pollock C; Wheeler DC; Yavin Y; Zhang H; Zinman B; Meininger G; Brenner BM; Mahaffey KW; Jha V, 2019, 'Canagliflozin and renal outcomes in type 2 diabetes and nephropathy', New England Journal of Medicine, 380, pp. 2295 - 2306, http://dx.doi.org/10.1056/NEJMoa1811744

LI J; BADVE SV; ZHOU Z; OH R; LEE M; PERKOVIC V; ZEEUW DD; MAHAFFEY KW; FULCHER G; MATTHEWS DR; NEAL B, 2019, '1216-P: The Effects of Canagliflozin on Uric Acid and Gout in Patients with Type 2 Diabetes in the CANVAS Program', Diabetes, 68, http://dx.doi.org/10.2337/db19-1216-p

MAHAFFEY KW; IANUS J; DAMARAJU CV; NEAL B; ZEEUW DD; FULCHER G; PFEIFER M; MATTHEWS DR, 2019, 'Cause of Hospitalizations in Patients with Type 2 Diabetes Mellitus (T2DM) in the CANVAS Program', Diabetes, 68, http://dx.doi.org/10.2337/db19-1203-p

MATTHEWS DR; WYSHAM CH; DAVIES MJ; SLEE A; ALBA M; LEE M; CAPUANO G; PERKOVIC V; MAHAFFEY KW; NEAL B, 2019, 'Effects of Canagliflozin (CANA) on Initiation of Insulin in CANVAS Program', Diabetes, 68, http://dx.doi.org/10.2337/db19-1206-p

Oshima M; Ohkuma T; Neal B; Li Q; De Zeeuw D; Mahaffey KW; Fulcher G; Canovatchel W; Matthews DR; Perkovic V; Li Q, 2019, 'FP484DIFFERENT eGFR THRESHOLDS AND THE RENAL EFFECTS OF CANAGLIFLOZIN: DATA FROM THE CANVAS PROGRAM', Nephrology Dialysis Transplantation, 34, pp. gfz106.fp484, http://dx.doi.org/10.1093/ndt/gfz106.fp484

Jin A; Feng X; Zhang R; Wang H; Qiao Q; Feng L; Gao P; Fang H; Neal B; Liu K; Labarthe D; Wu Y, 2019, 'Impact of Salt Substitute and Stepwise Reduction of Salt Supply on Blood Pressure in the Elderly in Nursing Homes (DECIDE-Salt Trial): Protocol and Baseline Characteristics (P13-022-19)', Current Developments in Nutrition, 3, pp. 3013579, http://dx.doi.org/10.1093/cdn/nzz036.p13-022-19

Campbell NRC; He FJ; Tan M; Cappuccio FP; Neal B; Woodward M; Cogswell ME; McLean R; Arcand J; MacGregor G; Whelton P; Jula A; L'Abbe MR; Cobb LK; Lackland DT, 2019, 'The International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) position statement on the use of 24-hour, spot, and short duration (<24 hours) timed urine collections to assess dietary sodium intake', Journal of Clinical Hypertension, 21, pp. 700 - 709, http://dx.doi.org/10.1111/jch.13551

Jones A; Thow AM; Ni Mhurchu C; Sacks G; Neal B, 2019, 'The performance and potential of the Australasian Health Star Rating system: a four-year review using the RE-AIM framework', Australian and New Zealand Journal of Public Health, 43, pp. 355 - 365, http://dx.doi.org/10.1111/1753-6405.12908

Figtree GA; Rådholm K; Barrett TD; Perkovic V; Mahaffey KW; De Zeeuw D; Fulcher G; Matthews DR; Shaw W; Neal B, 2019, 'Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus: Results From the CANVAS Program', Circulation, 139, pp. 2591 - 2593, http://dx.doi.org/10.1161/CIRCULATIONAHA.119.040057

Toyama T; Neuen BL; Jun M; Ohkuma T; Neal B; Jardine MJ; Heerspink HL; Wong MG; Ninomiya T; Wada T; Perkovic V, 2019, 'Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis', Diabetes, Obesity and Metabolism, 21, pp. 1237 - 1250, http://dx.doi.org/10.1111/dom.13648

Neuen B; Heerspink H; Neal B; Matthews D; de Zeeuw D; Mahaffey K; Davidson J; Jardine M; Zoungas S; Perkovic V, 2019, 'Abstract #259 Cardiovascular and Renal Outcomes with Canagliflozin in People with Type 2 Diabetes According to Baseline use of Metformin', Endocrine Practice, 25, pp. 99 - 100, http://dx.doi.org/10.1016/s1530-891x(20)46603-0

Figtree G; Rådholm K; Barrett TD; Perkovic V; Mahaffey KW; de Zeeuw D; Fulcher G; Matthews DR; Shaw W; Neal B, 2019, 'EFFECTS OF CANAGLIFLOZIN ON HEART FAILURE OUTCOMES WITH AND WITHOUT PRESERVED EJECTION FRACTION IN TYPE 2 DIABETES: RESULTS FROM THE CANVAS PROGRAM', Journal of the American College of Cardiology, 73, pp. 685, http://dx.doi.org/10.1016/s0735-1097(19)31293-8

Talati Z; Pettigrew S; Kelly B; Ball K; Neal B; Dixon H; Shilton T; Miller C, 2019, 'Corrigendum: Can front-of-pack labels influence portion size judgements for unhealthy foods? (Public Health Nutrition (2018) 21:15 (2776-2781) DOI: 10.1017/S1368980018001702)', Public Health Nutrition, 22, pp. 571 - 572, http://dx.doi.org/10.1017/S1368980018003099

Cleghorn C; Blakely T; Mhurchu CN; Wilson N; Neal B; Eyles H, 2019, 'Estimating the health benefits and cost-savings of a cap on the size of single serve sugar-sweetened beverages', Preventive Medicine, 120, pp. 150 - 156, http://dx.doi.org/10.1016/j.ypmed.2019.01.009

Figtree GA; Rådholm K; Neal B, 2019, 'Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"', Circulation, 139, pp. 418 - 419, http://dx.doi.org/10.1161/circulationaha.118.038477

Ohkuma T; Jun M; Rodgers A; Cooper ME; Glasziou P; Hamet P; Harrap S; Mancia G; Marre M; Neal B; Perkovic V; Poulter N; Williams B; Zoungas S; Chalmers J; Woodward M, 2019, 'Acute Increases in Serum Creatinine after Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial', Hypertension, 73, pp. 84 - 91, http://dx.doi.org/10.1161/HYPERTENSIONAHA.118.12060

Zhou Z; Lindley RI; Rådholm K; Jenkins B; Watson J; Perkovic V; Mahaffey KW; De Zeeuw D; Fulcher G; Shaw W; Oh R; Desai M; Matthews DR; Neal B, 2019, 'Canagliflozin and Stroke in Type 2 Diabetes Mellitus: Results from the Randomized CANVAS Program Trials', Stroke, 50, pp. 396 - 404, http://dx.doi.org/10.1161/STROKEAHA.118.023009

Neuen BL; Ohkuma T; Neal B; Matthews DR; De Zeeuw D; Mahaffey KW; Fulcher G; Li Q; Jardine M; Oh R; Heerspink HL; Perkovic V, 2019, 'Effect of canagliflozin on renal and cardiovascular outcomes across different levels of albuminuria: Data from the CANVAS program', Journal of the American Society of Nephrology, 30, pp. 2229 - 2242, http://dx.doi.org/10.1681/ASN.2019010064

Salam A; Atkins E; Sundström J; Hirakawa Y; Ettehad D; Emdin C; Neal B; Woodward M; Chalmers J; Berge E; Yusuf S; Rahimi K; Rodgers A, 2019, 'Effects of blood pressure lowering on cardiovascular events, in the context of regression to the mean: A systematic review of randomized trials', Journal of Hypertension, 37, pp. 16 - 23, http://dx.doi.org/10.1097/HJH.0000000000001994

Matthews DR; Li Q; Perkovic V; Mahaffey KW; de Zeeuw D; Fulcher G; Desai M; Hiatt WR; Nehler M; Fabbrini E; Kavalam M; Lee M; Neal B, 2019, 'Effects of canagliflozin on amputation risk in type 2 diabetes: the CANVAS Program', Diabetologia, 62, pp. 926 - 938, http://dx.doi.org/10.1007/s00125-019-4839-8

Mhurchu CN; Volkova E; Jiang Y; Neal B; Eyles H; Blakely T; Swinburn B; Rayner M, 2019, 'Effects of interpretive front-of-pack nutrition labels on consumer food purchases: A randomized controlled trial', Obesity Research & Clinical Practice, 13, pp. 62, http://dx.doi.org/10.1016/j.orcp.2016.10.088

Selak V; Webster R; Stepien S; Bullen C; Patel A; Thom S; Arroll B; Bots ML; Brown A; Crengle S; Dorairaj P; Elley CR; Grobbee DE; Harwood M; Hillis GS; Laba TL; Neal B; Peiris D; Rafter N; Reid C; Stanton A; Tonkin A; Usherwood T; Wadham A; Rodgers A, 2019, 'Reaching cardiovascular prevention guideline targets with a polypill-based approach: A meta-Analysis of randomised clinical trials', Heart, 105, pp. 42 - 48, http://dx.doi.org/10.1136/heartjnl-2018-313108

Johnson C; Santos JA; Sparks E; Raj TS; Mohan S; Garg V; Rogers K; Maulik PK; Prabhakaran D; Neal B; Webster J; Santos JA, 2019, 'Sources of dietary salt in North and South India estimated from 24 hour dietary recall', Nutrients, 11, pp. 318, http://dx.doi.org/10.3390/nu11020318

Baldridge AS; Huffman MD; Taylor F; Xavier D; Bright B; Van Horn LV; Neal B; Dunford E, 2019, 'The healthfulness of the US packaged food and beverage supply: A cross-sectional study', Nutrients, 11, pp. 1704, http://dx.doi.org/10.3390/nu11081704

Pettigrew S; Talati Z; Miller C; Dixon H; Kelly B; Neal B; Ball K; Hughes C; Shilton T, 2019, 'Attributes used by consumers to assess alternative front-of-pack food labelling systems', Obesity Research & Clinical Practice, 13, pp. 63, http://dx.doi.org/10.1016/j.orcp.2016.10.090

Talati Z; Pettigrew S; Norman R; Kelly B; Dixon H; Neal B; Miller C, 2019, 'Can front-of-pack nutrition labels overcome any biasing effects of nutrient and health claims?', Obesity Research & Clinical Practice, 13, pp. 247, http://dx.doi.org/10.1016/j.orcp.2018.11.033

Talati Z; Pettigrew S; Hughes C; Dixon H; Kelly B; Ball K; Miller C; Neal B; Shilton T, 2019, 'The potential of front-of-pack labels on unhealthy foods to counteract the misleading effects of health claims', Obesity Research & Clinical Practice, 13, pp. 62 - 63, http://dx.doi.org/10.1016/j.orcp.2016.10.089

Talati Z; Norman R; Kelly B; Dixon H; Neal B; Miller C; Pettigrew S, 2018, 'A randomized trial assessing the effects of health claims on choice of foods in the presence of front-of-pack labels', American Journal of Clinical Nutrition, 108, pp. 1275 - 1282, http://dx.doi.org/10.1093/ajcn/nqy248

Dunford EK; Ni Mhurchu C; Vandevijvere S; Swinburn B; Kušar A; Pravst I; Tolentino-Mayo L; Reyes M; L’Abbe M; Neal BC, 2018, 'The comparative healthiness of 367,500 packaged food and beverages from 12 countries', European Journal of Public Health, 28, http://dx.doi.org/10.1093/eurpub/cky213.680

Carcel C; Neal B; Oparil S; Narkiewicz K; Wang J; Schiffrin E; Azizi M; Poulter N; Chalmers J, 2018, 'A7958 Prevalence and clinical characteristics of patients with treatment resistant hypertension by region', Journal of Hypertension, 36, pp. e306, http://dx.doi.org/10.1097/01.hjh.0000549252.23988.4b

Talati Z; Pettigrew S; Kelly B; Ball K; Neal B; Dixon H; Shilton T; Miller C, 2018, 'Can front-of-pack labels influence portion size judgements for unhealthy foods?', Public Health Nutrition, 21, pp. 2776 - 2781, http://dx.doi.org/10.1017/S1368980018001702

Perkovic V; de Zeeuw D; Mahaffey KW; Fulcher G; Erondu N; Shaw W; Barrett TD; Weidner-Wells M; Deng H; Matthews DR; Neal B, 2018, 'Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials', The Lancet Diabetes and Endocrinology, 6, pp. 691 - 704, http://dx.doi.org/10.1016/S2213-8587(18)30141-4

Lucko AM; Doktorchik C; Woodward M; Cogswell M; Neal B; Rabi D; Anderson C; He FJ; MacGregor GA; L'Abbe M; Arcand JA; Whelton PK; McLean R; Campbell NRC, 2018, 'Percentage of ingested sodium excreted in 24-hour urine collections: A systematic review and meta-analysis', Journal of Clinical Hypertension, 20, pp. 1220 - 1229, http://dx.doi.org/10.1111/jch.13353

Dunford EK; Huang L; Peters SAE; Crino M; Neal BC; Ni Mhurchu C, 2018, 'Evaluation of alignment between the health claims nutrient profiling scoring criterion (NPSC) and the health star rating (HSR) nutrient profiling models', Nutrients, 10, pp. 1065, http://dx.doi.org/10.3390/nu10081065

Schrieks IC; Nozza A; Stähli BE; Buse JB; Henry RR; Malmberg K; Neal B; Nicholls SJ; Rydén L; Mellbin L; Svensson A; Wedel H; Weichert A; Lincoff AM; Tardif JC; Grobbee DE; Schwartz GG, 2018, 'Adiponectin, free fatty acids, and cardiovascular outcomes in patients with type 2 diabetes and acute coronary syndrome', Diabetes Care, 41, pp. 1792 - 1800, http://dx.doi.org/10.2337/dc18-0158

Gupta P; Mohan S; Johnson C; Garg V; Thout SR; Shivashankar R; Krishnan A; Neal B; Prabhakaran D, 2018, 'Stakeholders’ perceptions regarding a salt reduction strategy for India: Findings from qualitative research', PLoS ONE, 13, pp. e0201707, http://dx.doi.org/10.1371/journal.pone.0201707

Jones A; Shahid M; Neal B, 2018, 'Uptake of australia’s health star rating system', Nutrients, 10, pp. 997, http://dx.doi.org/10.3390/nu10080997

Eyles H; Jiang Y; Blakely T; Neal B; Crowley J; Cleghorn C; Ni Mhurchu C, 2018, 'Five year trends in the serve size, energy, and sodium contents of New Zealand fast foods: 2012 to 2016', Nutrition Journal, 17, pp. 65, http://dx.doi.org/10.1186/s12937-018-0373-7

Stähli BE; Nozza A; Schrieks IC; Buse JB; Malmberg K; Mellbin L; Neal B; Nicholls SJ; Rydén L; Svensson A; Wedel H; Weichert A; Lincoff AM; Grobbee DE; Tardif JC; Schwartz GG, 2018, 'Homeostasis model assessment of insulin resistance and survival in patients with diabetes and acute coronary syndrome', Journal of Clinical Endocrinology and Metabolism, 103, pp. 2522 - 2533, http://dx.doi.org/10.1210/jc.2017-02772

Rådholm K; Wu JH; Wong MG; Foote C; Fulcher G; Mahaffey KW; Perkovic V; Neal B, 2018, 'Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular disease, death and safety outcomes in type 2 diabetes – A systematic review', Diabetes Research and Clinical Practice, 140, pp. 118 - 128, http://dx.doi.org/10.1016/j.diabres.2018.03.027

Crino M; Sacks G; Dunford E; Trieu K; Webster J; Vandevijvere S; Swinburn B; Wu JY; Neal B, 2018, 'Measuring the healthiness of the packaged food supply in Australia', Nutrients, 10, pp. 702, http://dx.doi.org/10.3390/nu10060702

Morton RL; Schlackow I; Gray A; Emberson J; Herrington W; Staplin N; Reith C; Howard K; Landray MJ; Cass A; Baigent C; Mihaylova B; Collins R; Bray C; Chen Y; Baxter A; Young A; Hill M; Knott C; Feldt-Rasmussen B; Fellström B; Grobbee DE; Grönhagen-Riska C; Haas M; Holdaas H; Hooi LS; Jiang L; Kasiske B; Krairittichai U; Levin A; Massy ZA; Tesar V; Walker R; Wanner C; Wheeler DC; Wiecek A; Dasgupta T; Lewis D; Mafham M; Majoni W; Parish S; Simpson D; Strony J; Musliner T; Agodoa L; Armitage J; Chen Z; Craig J; de Zeeuw D; Gaziano JM; Grimm R; Krane V; Neal B; Ophascharoensuk V; Pedersen T; Sleight P; Tobert J; Tomson C, 2018, 'Impact of CKD on Household Income', Kidney International Reports, 3, pp. 610 - 618, http://dx.doi.org/10.1016/j.ekir.2017.12.008

Zhou Z; Yu J; Carcel C; Delcourt C; Shan J; Lindley RI; Neal B; Anderson CS; Hackett ML, 2018, 'Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: Systematic review and meta-analysis', BMJ Open, 8, pp. e019672, http://dx.doi.org/10.1136/bmjopen-2017-019672

Jones A; Rådholm K; Neal B, 2018, 'Defining ‘unhealthy’: A systematic analysis of alignment between the australian dietary guidelines and the health star rating system', Nutrients, 10, pp. 501, http://dx.doi.org/10.3390/nu10040501

Yin X; Neal B; Tian M; Li Z; Petersen K; Komatsu Y; Feng X; Wu Y, 2018, 'Sodium and potassium content of 24 h urinary collections: A comparison between field-and laboratory-based analysers', Public Health Nutrition, 21, pp. 1036 - 1042, http://dx.doi.org/10.1017/S1368980017003731

Karmali KN; Lloyd-Jones DM; van der Leeuw J; Goff DC; Yusuf S; Zanchetti A; Glasziou P; Jackson R; Woodward M; Rodgers A; Neal BC; Berge E; Teo K; Davis BR; Chalmers J; Pepine C; Rahimi K; Sundström J, 2018, 'Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant data', PLoS Medicine, 15, pp. e1002538, http://dx.doi.org/10.1371/journal.pmed.1002538

Land MA; Neal BC; Johnson C; Nowson CA; Margerison C; Petersen KS, 2018, 'Salt consumption by australian adults: A systematic review and meta-analysis', Medical Journal of Australia, 208, pp. 75 - 81, http://dx.doi.org/10.5694/mja17.00394

Mahaffey KW; Neal B; Perkovic V; De Zeeuw D; Fulcher G; Erondu N; Shaw W; Fabbrini E; Sun T; Li Q; Desai M; Matthews DR, 2018, 'Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results from the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)', Circulation, 137, pp. 323 - 334, http://dx.doi.org/10.1161/CIRCULATIONAHA.117.032038

Rådholm K; Figtree G; Perkovic V; Solomon SD; Mahaffey KW; De Zeeuw D; Fulcher G; Barrett TD; Shaw W; Desai M; Matthews DR; Neal B, 2018, 'Canagliflozin and heart failure in type 2 diabetes mellitus: Results from the CANVAS program', Circulation, 138, pp. 458 - 468, http://dx.doi.org/10.1161/CIRCULATIONAHA.118.034222

Neuen BL; Ohkuma T; Neal B; Matthews DR; De Zeeuw D; Mahaffey KW; Fulcher G; Desai M; Li Q; Deng H; Rosenthal N; Jardine MJ; Bakris G; Perkovic V, 2018, 'Cardiovascular and renal outcomes with canagliflozin according to baseline kidney function data from the CANVAS program', Circulation, 138, pp. 1537 - 1550, http://dx.doi.org/10.1161/CIRCULATIONAHA.118.035901

Back to profile page